This book examines the impact of economic reforms in India on the pharmaceutical industry & access to medicines. It traces the changing production & trade pattern of the industry, research & development (R&D) preferences & strategies of Indian pharmaceutical firms, patent system alongside pricing policy measures & their shortcomings. It also analyses the public health financing system in India driven largely by out-of-pocket expenditure - about 60 % - & characterised by very high share of medicines in total health expenditure. A masterful insight into a topical area, it will be indispensable to those working on pharmaceutical industry & public policy & will be of interest to researchers, scholars, students, & policy-makers of economics, industrial policy, public policy, intellectual property rights & health financing.